Please Wait.....
Report
Asia Pacific Cell Sheet-based Gene Therapy Market By Sheet Type (Monolayer Cell-sheet, Co-culture Cell-sheet, Multilayered Cell-sheet, Others), By Application (Oncology, Ophthalmology, Genetic Disorders, Cardiology, Others), By Country, Competition, Forecast & Opportunities, 2020-2030F
Market Report I 2025-08-25 I 130 Pages I TechSci Research
Market Overview
Asia Pacific Cell Sheet-based Gene Therapy Market was valued at USD 168.72 Million in 2024 and is expected to reach USD 233.71 Million by 2030 with a CAGR of 5.78%. This growth is being driven by a combination of factors, including increasing investments in research and development, the rising incidence of chronic and degenerative diseases, and continuous advancements in tissue engineering technologies. Countries such as Japan, South Korea, China, and Australia are emerging as key players in both clinical and commercial applications of cell sheet-based gene therapies.
One of the primary drivers of market expansion is the region's growing healthcare expenditure. Governments and private sectors are allocating substantial resources toward the development and adoption of innovative treatments for complex conditions such as cancer, cardiovascular diseases, and age-related disorders. Despite the positive outlook, the Asia-Pacific market faces several challenges. These include high costs associated with the production and scale-up of cell sheet-based therapies, limited standardization in manufacturing processes, and the complexities of navigating differing regulatory requirements across multiple jurisdictions.
Key Market Drivers
Growth in Healthcare Industry
The rapid expansion of the healthcare industry across the Asia Pacific region is emerging as a key driver for the cell sheet-based gene therapy market. Asia is firmly establishing itself as a global economic powerhouse, with its healthcare market poised for unprecedented growth. Forecasted to reach approximately USD 5 trillion by 2030, the region is expected to drive 40% of global healthcare expansion, propelled by key demographic shifts. One of the most significant contributors to this growth is the increasing demand for personalized and regenerative medicine. As populations age and the prevalence of chronic and degenerative diseases rises, healthcare systems are shifting toward more innovative treatment modalities. Cell sheet-based gene therapy, which offers targeted and minimally invasive therapeutic approaches, aligns well with these evolving medical needs.
Moreover, advancements in biotechnology, growing adoption of stem cell research, and supportive regulatory frameworks are further accelerating the integration of gene therapies into mainstream healthcare services. For instance, countries such as Japan have introduced expedited approval processes for regenerative medicines, creating a favorable environment for clinical trials and commercialization. India is advancing stem cell research by focusing on both basic and translational studies. The evolving strategy includes establishing Centers of Excellence, creating a virtual research network, generating human embryonic stem cell lines, and developing talent through training and international fellowships.
Key Market Challenges
High Production & Operational Costs
One of the foremost challenges facing the Asia-Pacific cell sheet-based gene therapy market is the high production and operational costs associated with these advanced therapies. The manufacturing of cell sheet-based gene therapies involves complex, multi-step processes that require specialized facilities, sophisticated equipment, and highly skilled personnel. These factors collectively drive up the cost of production, making it difficult for companies to achieve economies of scale or offer competitive pricing.
Furthermore, maintaining stringent quality control and regulatory compliance throughout the production cycle adds additional layers of operational expense. The need for cleanroom environments, aseptic processing, and continuous monitoring to ensure product consistency and safety further inflates costs. In a region as diverse as Asia-Pacific, with varying infrastructure capabilities and regulatory requirements, these operational challenges are compounded.
Key Market Trends
Rising Prevalence of Chronic and Genetic Diseases
A notable trend influencing the Asia Pacific cell sheet-based gene therapy market is the rising prevalence of chronic and genetic diseases across the region. Chronic diseases represent a significant share of mortality in the South-East Asia Region, varying from 34% in Timor-Leste to 79% in the Maldives. Driven by an epidemiological transition towards noncommunicable diseases, the prevalence and impact of chronic conditions continue to rise steadily. With rapid urbanization, lifestyle changes, and an aging population, the incidence of conditions such as cancer, cardiovascular diseases, diabetes, and hereditary disorders has been steadily increasing. This surge in chronic and genetic ailments is driving demand for innovative and effective treatment solutions.
Cell sheet-based gene therapy presents a promising approach for addressing these complex diseases by enabling targeted, regenerative treatment that can potentially correct genetic abnormalities and restore damaged tissues. The technology's ability to offer personalized and minimally invasive therapies is particularly appealing in managing conditions that have limited treatment options or require long-term care.
Key Market Players
- Emmaus International
- CellSeed Inc.
- FUJIFILM Holdings Corporation
- Japan Tissue Engineering Co. Ltd.
Report Scope
In this report, the Asia Pacific Cell Sheet-based Gene Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Asia Pacific Cell Sheet-based Gene Therapy Market, By Sheet Type:
o Monolayer Cell-sheet
o Co-culture Cell-sheet
o Multilayered Cell-sheet
o Others
- Asia Pacific Cell Sheet-based Gene Therapy Market, By Application:
o Oncology
o Ophthalmology
o Genetic Disorders
o Cardiology
o Others
- Asia Pacific Cell Sheet-based Gene Therapy Market, By Country:
o China
o India
o Japan
o Australia
o South Korea
o Rest of Asia Pacific
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Asia Pacific Cell Sheet-based Gene Therapy Market.
Available Customizations:
Asia Pacific Cell Sheet-based Gene Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Asia Pacific Cell Sheet-based Gene Therapy Market
5. Asia Pacific Cell Sheet-based Gene Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Sheet Type (Monolayer Cell-sheet, Co-culture Cell-sheet, Multilayered Cell-sheet, Others)
5.2.2. By Application (Oncology, Ophthalmology, Genetic Disorders, Cardiology, Others)
5.2.3. By Country
5.2.4. By Company (2024)
5.3. Market Map
6. China Cell Sheet-based Gene Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Sheet Type
6.2.2. By Application
7. India Cell Sheet-based Gene Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Sheet Type
7.2.2. By Application
8. Japan Cell Sheet-based Gene Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Sheet Type
8.2.2. By Application
9. South Korea Cell Sheet-based Gene Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Sheet Type
9.2.2. By Application
10. Australia Cell Sheet-based Gene Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Sheet Type
10.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
14. Asia Pacific Cell Sheet-based Gene Therapy Market: SWOT Analysis
15. Porters Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Emmaus International
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. CellSeed Inc.
16.3. FUJIFILM Holdings Corporation
16.4. Japan Tissue Engineering Co. Ltd.
17. Strategic Recommendations
18. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security